scholarly journals Get vaccinated when it is your turn and follow the local guidelines

2021 ◽  
Vol 5 (3) ◽  
Author(s):  
I Wayan Suryasa ◽  
María Rodríguez-Gámez ◽  
Tihnov Koldoris
Keyword(s):  
Infectious Disease ◽  
Cardiovascular Disease ◽  
Older People ◽  
Respiratory Disease ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Special Treatment ◽  
Infected Person ◽  
Medical Conditions ◽  
Respiratory Droplets

The nurse has an important role caring for the patient infected with the coronavirus disease (COVID- 19). It is an infectious disease caused by the SARS-CoV-2 virus. The virus can spread from the mouth or nose of an infected person in small liquid particles when they cough, sneeze, speak, sing, or breathe. These particles range from larger respiratory droplets to smaller aerosols. It is important to practice respiratory etiquette, for example coughing into a flexed elbow, and to stay home and self-isolate until you recover if you feel unwell. Most people infected with the virus will experience mild to moderate respiratory illness and will recover without requiring special treatment. Older people and people with underlying medical conditions such as cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illnesses. The goal of the research is to propose the best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads. Protect yourself and others from infection by staying at least 1 meter away from others, wearing a well-fitting mask, and washing your hands or using an alcohol-based rub frequently.

scholarly journals Why there are and will be less deaths in India due to COVID-19: an insight

2020 ◽  
Vol 7 (8) ◽  
pp. 3301
Author(s):  
Chincholikar Sanjeev Vasantrao
Keyword(s):  
Cardiovascular Disease ◽  
Respiratory Disease ◽  
Kidney Diseases ◽  
Heart Diseases ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Special Treatment ◽  
Medical Problems ◽  
Health Organization

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. It has been declared a pandemic by the World Health Organization which exhibited human-to-human transmissibility and spread rapidly across countries. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Climate, with temperature, humidity, Bacillus Calmette–Guérin (BCG) vaccination, immune status of persons, elderly people, uncontrolled co morbid conditions like heart diseases, diabetes mellitus, hypertension, kidney diseases seems to play an important role in spread and severity of corona virus infection. As reported from MOHFW website, the COVID-19 deaths are more in above 60 years of age with comorbidities cardiovascular disease, diabetes, chronic respiratory disease, and cancer.

scholarly journals A Review on Current Situation of Coronavirus (COVID-19)

2021 ◽  
pp. 28-32
Author(s):  
Arif S. Shekh ◽  
Jayshri V. Thorat ◽  
Aijaz A. Sheikh ◽  
K. R. Biyani
Keyword(s):  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Medical Problem ◽  
Special Treatment ◽  
Infected Person ◽  
Virus Spread ◽  
Serious Illness ◽  
Respiratory Droplets ◽  
Corona Viruses ◽  
Primary Transmission

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people and those with underlying medical problem like cardiovascular disease, Diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The best way to prevent and solve down transmission is to be well informed it causes and how it spread. Protect yourself and other from infection by washing your hands or using alcohol base rub frequently and not touching your face. The COVID-19 virus spread primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes, so it’s important that you also practice respiratory etiquette (for ex. by coughing into a flexed elbow).The COVID-19 is a respiratory illness and the primary transmission of C0VID-19 route is through person to person contact and through when a contact infected person coughs or sneezes with respiratory droplets. No evidence of viruses that causes respiratory illness being transmitted via food or packaging. Corona viruses multiply in animal or human host, they cannot multiply in food.

Respiratory disorders

2013 ◽  
pp. 372-397
Author(s):  
Keith T. Palmer ◽  
Paul Cullinan
Keyword(s):  
Respiratory Disease ◽  
Sickness Absence ◽  
Hospital Admissions ◽  
Respiratory Illness ◽  
Work Capacity ◽  
Chronic Respiratory Disease ◽  
Respiratory Illnesses ◽  
Respiratory Problems ◽  
Work Settings ◽  
Working Age

Respiratory illnesses commonly cause sickness absence, unemployment, medical attendance, illness, and handicap.1 Collectively these disorders cause 19 million days/year of certified sickness absence in men and 9 million days/year in women (with substantial additional lost time from self-certified illness) and, among adults of working age, a general practitioner consultation rate of 48.5 per 100/year with more than 240 000 hospital admissions/year. Prescriptions for bronchodilator inhalers run at some 24 million/year, and mortality from respiratory disease causes an estimated loss of 164 000 working years by age 64 and an estimated annual production loss of £1.6 billion (at prices in 2000). Respiratory disease may be caused, and pre-existing disease may be exacerbated, by the occupational environment. More commonly, respiratory disease limits work capacity and the ability to undertake particular duties. Finally, individual respiratory fitness in ‘safety critical’ jobs can have implications for work colleagues and the public. Within this broad picture, different clinical illnesses pose different problems. For example, acute respiratory illness commonly causes short-term sickness absence, whereas chronic respiratory disease has a greater impact on long-term absence and work limitation; and the fitness implications of respiratory sensitization at work are very different from non-specific asthma aggravated by workplace irritants. Occupational causes of respiratory disease represent a small proportion of the burden, except in some specialized work settings where particular exposures give rise to particular disease excesses. The corollary is that the common fitness decisions on placement, return to work, and rehabilitation more often involve non-occupational illnesses than occupational ones. By contrast, statutory programmes of health surveillance focus on specific occupational risks (e.g. baking) and specific occupational health outcomes (e.g. occupational asthma). In assessing the individual it is important to remember that respiratory problems are often aggravated by other illnesses, particularly disorders of the cardiovascular and musculoskeletal systems.

THE EFFECTS OF CORONAVIRUS (COVID-19) IN ENGLISH LANGUAGE AND LITERATURE CLASSROOM OF GUJARAT STATE.

2020 ◽  
pp. 74-79
Author(s):  
Om Joshi
Keyword(s):  
English Language ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Language Teachers ◽  
Special Treatment ◽  
Family Welfare ◽  
Medical Problems ◽  
Gujarat State ◽  
Literature Classroom ◽  
Language And Literature

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.Coronavirus disease (COVID-19) has taken so many innocent lives, as it spread most of the corner of the world and Gujarat, India oneof them. At present March 2020, most of the institutes and universities do ready to complete the course and repeats the topic in the classroom. As we know that, because of Coronavirus disease (COVID19)University Grants Commission, Health and Family Welfare Department and Education Department, Govt. of Gujaratinstructed to all the institutes and universities to remain closed till further instructions.In this period, researcher wishes to knowthe situation of the English language and literature classroom of Gujarat state. Researcher will refer the online circularsof different institutes and universities of Gujaratstate andwill do the telephonic interviews of English language teachers, based on the data, researcher will discuss the effects of Coronavirus disease (COVID-19) in English language and literature classroom.

SARS-CoV-2 and COVID-19

2021 ◽  
Author(s):  
Rosalind Hollingsworth
Keyword(s):  
Distress Syndrome ◽  
Multiorgan Failure ◽  
Mainland China ◽  
Respiratory Illness ◽  
Infected Person ◽  
Increased Risk ◽  
Asymptomatic Infections ◽  
Novel Coronavirus ◽  
Inflammatory Syndrome ◽  
Respiratory Droplets

Coronavirus disease 19 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus which emerged in Wuhan, China in 2019, and from there spread to other parts of mainland China and around the world. The virus spreads mainly through respiratory droplets produced when an infected person coughs, sneezes, or speaks. On average, the time from exposure to SARS-CoV-2 to the appearance of symptoms is 5–6 days but can range from 1–14 days. Asymptomatic infections with SARS-CoV-2 can occur. In those with symptoms, most people (approx. 80%) will experience a mild to moderate respiratory illness and recover without hospital management. Adults 65 years of age and older, and individuals of any age with underlying medical conditions, are at increased risk for severe COVID-19 and death. Complications include respiratory failure, acute respiratory distress syndrome, sepsis/septic shock, thromboembolism, multiorgan failure and death. In rare cases, children and adults can develop a severe inflammatory syndrome a few weeks after SARS-COV-2 infection. Vaccines are available to help prevent COVID-19 disease; by August 2021, 7 vaccines had been authorized for use by the WHO to prevent COVID-19 caused by SARS-CoV-2, with others approved by country regulatory authorities.

Global Pandemic of a Century: A Review on the Coronavirus (COVID-19)

2020 ◽  
Vol 7 (4) ◽  
pp. 17-26
Author(s):  
Jitendra Mehta ◽  
Keyword(s):  
Respiratory Disease ◽  
Rna Virus ◽  
Severe Disease ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Director General ◽  
Global Pandemic ◽  
The World ◽  
Health Organization

Coronavirus disease 2019 (COVID-19) emerged in December 2019 in Wuhan, the capital of Hubei province, China. While the outbreak in China is almost over, this highly contagious disease is currently spreading across the world with a daily increase in the number of affected countries, confirmed cases, and infection-related deaths. In January, the World Health Organization (WHO) declared that the outbreak of COVID-19 constituted a Public Health Emergency of International Concern (PHEIC). Based on the high levels of global spread and the severity of COVID-19, on 11 March 2020, the Director-General of the WHO declared the COVID-19 outbreak a pandemic. COVID-19 is an acute respiratory disease caused by a newly emerged zoonotic coronavirus. A positive-sense enveloped single-stranded RNA virus, named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been isolated from a patient with pneumonia and connected to the cluster of acute respiratory illness cases from Wuhan. The virus is transmitted from human to human via droplets coughed or exhaled by infected persons and by touching droplet-contaminated surfaces or objects and then touching the eyes, nose, or mouth. Population groups that have been more frequently reported as having severe disease and a higher mortality rate include people aged over 60 years, males, people with underlying conditions such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease, and cancer. Current estimates suggest a median incubation period of five to six days for COVID-19, with a range of one to 14 days. Disease-specific pharmaceuticals and vaccines are still under research and development. The therapeutic use of convalescent plasma donated by patients recovered from COVID-19 might play a role in the efforts to find a possible treatment for COVID-19. Keywords: Coronavirus, COVID-19, WHO, SARS-Cov-2, Zoonotic.

scholarly journals A REVIEW TO SUMMARIZE THE AVAILABLE EVIDENCES ON TURMERIC'S (CURCUMA LONGA) MEDICINAL PROPERTIES TO UNDERSTAND THE SCOPE OF ITS EFFICACY IN THE TREATMENT AND PREVENTION OF COVID19 DISEASES.

2020 ◽  
pp. 7-14
Author(s):  
Vd. Anagha Kothadia ◽  
Geeta D. Parulkar
Keyword(s):  
Curcuma Longa ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Special Treatment ◽  
Intermediate Hosts ◽  
Medical Problems ◽  
Evidence Based Treatment ◽  
Routes Of Administration ◽  
Treatment And Prevention ◽  
Medicinal Properties

The massive outbreak of coronavirus disease (COVID-19) across the world, has affected more than 200 countries and territories which was originated in bats and transmitted to humans through unknown intermediate hosts in the Wuhan seafood market, China, in December of 2019. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. There is no system of medicine has any evidence-based treatment for COVID-19 yet and vaccine is recommended. WHO is helping to accelerate drug research. In India, Ministry of Ayush has issued guidelines which contain preventive and remedial information and advisories for the management of COVID19 symptoms. This review has assembled evidences of Turmeric/Curcuma longa which is one of the ingredient of the ayurvedic preventive majors issued by Ministry of Ayush and revealed various routes of administration of Turmeric /Curcuma longa asserted in Ayurvedic Texts as a remedy and additional preventive majors for COVID 19 symptoms.

scholarly journals The COVID-19 pandemic

2020 ◽  
Vol 68 (1) ◽  
pp. 7-8
Author(s):  
José Ricardo Navarrro-Vargas
Keyword(s):  
Infectious Disease ◽  
Intensive Care ◽  
Mortality Rate ◽  
Older People ◽  
Health Systems ◽  
Hospital Care ◽  
Respiratory Diseases ◽  
Respiratory Illness ◽  
Chronic Respiratory Diseases ◽  
Underlying Diseases

I open this note with some alarming figures: as of May 26, 2020, over 5 635 000 people have become infected and nearly 350 000 have died from the new coronavirus (COVID-19) worldwide.1 Meanwhile, in Colombia, there are already 21 981 people infected and 750 deaths from this disease, that is, a 3.4% mortality rate.2COVID-19 is an infectious disease caused by a new coronavirus strain. Most people infected with COVID-19 will develop a mild to moderate respiratory illness and recover without the need for hospital care. However, the disease can significantly affect older people and those with underlying diseases such as diabetes, chronic respiratory diseases, cancer, obesity, and cardiovasculardisease,3 and it could even lead to death, which undoubtedly places a burden on health systems, particularly on intensive care units (ICUs).

Sign in / Sign up

Export Citation Format

Share Document